In this episode of our Frontiers Health limited series of the pharmaphorum podcast, Deep Dive editor Eloise McLennan speaks ...

Having already voted unanimously that all pregnant women should be tested for hepatitis B as a precursor to deciding an HBV ...

Biogen has reached a deal to buy Alcyone Therapeutics, a privately held company that has developed a system for delivering ...

UK medtech firm Closed Loop Medicine has launched its first product in the US, a digital tool for personalising the dose of ...

The UK's Royal College of Psychiatrists (RCPsych) has published a report that calls for more clinical testing of psychedelic ...

Panellists voted by 8 to 3 – with one abstention – to change the CDC recommendations to state that MMRV is not recommended ...

In today's pharmaphorum podcast, host Jonah Comstock speaks with Alice Valder Curran, a partner at Hogan Lovells and our ...

Newly launched ophthalmology company Ollin Biosciences has emerged onto the scene with $100 million in backing and a mission to bring a rival drug for wet age-related macular degeneration (AMD) that ...

Dr Susan Monarez told lawmakers today that Health and Human Services (HHS) Secretary Robert F Kennedy Jr said he planned to ...

There is only one approved drug for ultra-rare disease fibrodysplasia ossificans progressiva (FOP) on the US market, but ...

Alzheimer’s and Parkinson’s pipelines are rapidly expanding beyond amyloid and into next-generation mechanisms such as ...

The $14.50-per-share deal equates to a purchase price of $2.4 billion at closing, with Roche dangling another $6 per share in ...